Anatara Lifesciences (ASX:ANR) Ending Cash Position : A$1.04 Mil (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Anatara Lifesciences Ending Cash Position?

Anatara Lifesciences's Ending Cash Position for the quarter that ended in Dec. 2023 was A$1.04 Mil.

Anatara Lifesciences's quarterly Ending Cash Position declined from Dec. 2022 (A$1.35 Mil) to Jun. 2023 (A$0.35 Mil) but then increased from Jun. 2023 (A$0.35 Mil) to Dec. 2023 (A$1.04 Mil).

Anatara Lifesciences's annual Ending Cash Position declined from Jun. 2021 (A$3.43 Mil) to Jun. 2022 (A$1.12 Mil) and declined from Jun. 2022 (A$1.12 Mil) to Jun. 2023 (A$0.35 Mil).

Anatara Lifesciences Ending Cash Position Historical Data

The historical data trend for Anatara Lifesciences's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anatara Lifesciences Ending Cash Position Chart

Anatara Lifesciences Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Ending Cash Position

Get a 7-Day Free Trial

1.36

2.68

3.43

1.12

0.35

Anatara Lifesciences Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Ending Cash Position	Get a 7-Day Free Trial														2.56	1.12	1.35	0.35	1.04

Anatara Lifesciences Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Anatara Lifesciences's Ending Cash Position for the fiscal year that ended in Jun. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1.12	+	-0.769
	=	0.35

Anatara Lifesciences's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0.352	+	0.683
	=	1.04

Anatara Lifesciences Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Anatara Lifesciences's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Anatara Lifesciences (ASX:ANR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anatara Lifesciences Ltd (ASX:ANR) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

c/- Perks, 81 Flinders Street, Level 8, Adelaide, SA, AUS, 5000

Website

https://www.anataralifesciences.com

Anatara Lifesciences Ltd is developing non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. Its products include the Gastrointestinal ReProgramming dietary supplement (GaRP) for humans and Detach for animals. It generates its income from license revenue.

Anatara Lifesciences (ASX:ANR) Headlines

No Headlines